You might not want to share your "bleak" forecast but I am more than happy to share mine.
The production forecast downgrade was disappointing but not totally unexpected due to labor shortages re covid and this will improve as the WA border reopens.
Slide 9 in the presentation states that the spod price Jan/Mar is expected to be in the range US$2600-$3000 and that increase will help offset the lower production.
Full Year Forecast 2021/22
Production 360,000
Av Spod price US$2050
EBITDAX AUD$730M
NPAT AUD $500M
PE 16.6
So if the Spodumene price holds up and production targets are achieved we will be looking at very low PE ratios, lots of surplus cash and very healthy dividends.
You might not want to share your "bleak" forecast but I am more...
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.18 |
Change
0.075(2.42%) |
Mkt cap ! $9.561B | |||
| Open | High | Low | Value | Volume |
| $3.13 | $3.19 | $3.11 | $9.884M | 3.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 87890 | $3.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.18 | 31930 | 11 |
View Market Depth
| Last trade - 10.50am 08/10/2024 (20 minute delay) ? |
| PLS (ASX) Chart |